227 related articles for article (PubMed ID: 28969714)
1. Pathogenesis and potential relative risk factors of diabetic neuropathic osteoarthropathy.
Zhao HM; Diao JY; Liang XJ; Zhang F; Hao DJ
J Orthop Surg Res; 2017 Oct; 12(1):142. PubMed ID: 28969714
[TBL] [Abstract][Full Text] [Related]
2. Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients.
Folestad A; Ålund M; Asteberg S; Fowelin J; Aurell Y; Göthlin J; Cassuto J
Acta Orthop; 2015; 86(4):415-25. PubMed ID: 25811776
[TBL] [Abstract][Full Text] [Related]
3. Neuropathy and the vascular-bone axis in diabetes: lessons from Charcot osteoarthropathy.
Petrova NL; Shanahan CM
Osteoporos Int; 2014 Apr; 25(4):1197-207. PubMed ID: 24091593
[TBL] [Abstract][Full Text] [Related]
4. [Diabetic neuropathic osteoarthropathy (Charcot foot)].
Rümenapf G; Lang W
Zentralbl Chir; 2003 Sep; 128(9):734-9. PubMed ID: 14533041
[TBL] [Abstract][Full Text] [Related]
5. Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density.
Herbst SA; Jones KB; Saltzman CL
J Bone Joint Surg Br; 2004 Apr; 86(3):378-83. PubMed ID: 15125125
[TBL] [Abstract][Full Text] [Related]
6. Management of the diabetic Charcot foot.
Frykberg RG; Mendeszoon E
Diabetes Metab Res Rev; 2000; 16 Suppl 1():S59-65. PubMed ID: 11054891
[TBL] [Abstract][Full Text] [Related]
7. Corneal Subbasal Nerve Plexus Changes in Severe Diabetic Charcot Foot Deformity: A Pilot Study in Search for a DNOAP Biomarker.
Herlyn A; Prakasam RK; Peschel S; Allgeier S; Köhler B; Winter K; Guthoff RF; Mittlmeier T; Stachs O
J Diabetes Res; 2018; 2018():5910639. PubMed ID: 30525053
[TBL] [Abstract][Full Text] [Related]
8. [Radiological and clinical aspects of diabetic-neuropathic osteoarthropathy].
Koller A; Fühner J; Wetz HH
Orthopade; 2004 Sep; 33(9):972-82. PubMed ID: 15316598
[TBL] [Abstract][Full Text] [Related]
9. The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes.
Jeffcoate WJ; Game F; Cavanagh PR
Lancet; 2005 Dec; 366(9502):2058-61. PubMed ID: 16338454
[TBL] [Abstract][Full Text] [Related]
10. Cartilage Damage Pathological Characteristics of Diabetic Neuropathic Osteoarthropathy.
Liu PL; Diao JY; Wang Q; Liu H; Zhang Y; Liang JQ; Zhang F; Liang XJ; Zhao HM
Anal Cell Pathol (Amst); 2023; 2023():7573165. PubMed ID: 37197158
[TBL] [Abstract][Full Text] [Related]
11. Confronting a dramatic situation: the charcot foot complicated by osteomyelitis.
Dalla Paola L
Int J Low Extrem Wounds; 2014 Dec; 13(4):247-62. PubMed ID: 25123373
[TBL] [Abstract][Full Text] [Related]
12. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes.
Petrova NL; Foster AV; Edmonds ME
Diabet Med; 2005 Jun; 22(6):756-61. PubMed ID: 15910628
[TBL] [Abstract][Full Text] [Related]
13. RANKL-RANK-OPG Pathway in Charcot Diabetic Foot: Pathophysiology and Clinical-Therapeutic Implications.
Greco T; Mascio A; Comisi C; Polichetti C; Caravelli S; Mosca M; Mondanelli N; Troiano E; Maccauro G; Perisano C
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769345
[TBL] [Abstract][Full Text] [Related]
14. [The diabetic foot].
Vestring T; Fiedler R; Greitemann B; Sciuk J; Peters PE
Radiologe; 1995 Jul; 35(7):447-55. PubMed ID: 7676022
[TBL] [Abstract][Full Text] [Related]
15. Increased uptake of bone radiopharmaceutical in diabetic neuropathy.
Edmonds ME; Clarke MB; Newton S; Barrett J; Watkins PJ
Q J Med; 1985 Dec; 57(224):843-55. PubMed ID: 4095254
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot: An 8.5-year prospective case-control study.
Jansen RB; Christensen TM; Bülow J; Rørdam L; Holstein PE; Jørgensen NR; Svendsen OL
J Diabetes Complications; 2018 Feb; 32(2):164-170. PubMed ID: 29196119
[TBL] [Abstract][Full Text] [Related]
17. Neuropathic osteoarthropathy in the diabetic foot.
Osterhouse MD; Kettner NW
J Manipulative Physiol Ther; 2002; 25(6):416-22. PubMed ID: 12183699
[TBL] [Abstract][Full Text] [Related]
18. Bone Mineral Density in Diabetes Mellitus Foot Patients for Prediction of Diabetic Neuropathic Osteoarthropathic Fracture.
Cho JH; Min TH; Chun DI; Won SH; Park SY; Kim K; Yi Y
J Bone Metab; 2020 Aug; 27(3):207-215. PubMed ID: 32911585
[TBL] [Abstract][Full Text] [Related]
19. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
[TBL] [Abstract][Full Text] [Related]
20. The causes of the Charcot syndrome.
Jeffcoate W
Clin Podiatr Med Surg; 2008 Jan; 25(1):29-42, vi. PubMed ID: 18165109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
